Scarica l'app Stockscreener
0.528
5.16%
0.0259
Dopo l'orario di chiusura:
.53
0.002
+0.38%
Reviva Pharmaceuticals Holdings Inc Borsa (RVPH) Ultime notizie
Reviva Pharmaceuticals Holdings Inc. Warrants (RVPHW) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Reviva Pharmaceuticals Holdings Inc. Warrants (RVPHW) Key Financial Ratios – Valuation, Profitability & More - valueresearchonline.com
Reviva Pharmaceuticals Holdings Inc. Warrants (RVPHW) Financials – Balance Sheet, Profit & Loss, Cash Flow - valueresearchonline.com
Reviva Pharmaceuticals Holdings Inc. Warrants (RVPHW) Peer Comparison – Compare with Others - Value Research
Reviva (RVPH) Earnings Snapshot: Profit Per Share Clears Its Benchmark in the Latest Reading; Market Move - vinanet.vn
Reviva Pharmaceuticals Holdings Inc. (NASDAQ: RVPH) Stock Price, News & Analysis - Kalkine
Reviva (RVPH) Results Review: EPS Lands Above Forecast in Latest Trading; Share Response: Shares Move 8.70% HigherProfit Recovery Report - vinanet.vn
RVPH: Patent Filed for New Formulation - Yahoo Finance
Reviva Pharmaceuticals Holdings Stock Price Forecast. Should You Buy RVPH? - StockInvest.us
Reviva Pharmaceuticals Holdings, Inc. Stock (RVPH)Quote OTC Markets - marketscreener.com
OTC Market Listing Exposes Reviva Pharmaceuticals to Volatility, Illiquidity and Pricing Risks - TipRanks
Barclays PLC (RVPH) discloses 20-share beneficial stake in Reviva common stock - Stock Titan
Reviva Q2 loss narrows to $2.4m; EPS beats estimate - scanx.trade
Form 8K Reviva Pharmaceuticals Holdings, Inc. For: 12 August By Investing.com - Investing.com Nigeria
Reviva Q2 loss narrows as brilaroxazine milestones approach - Quiver Quantitative
Reviva Reports Second Quarter 2026 Financial Results and Recent Business Highlights - The Manila Times
Reviva Seeks Accelerated Patent Review for Drug Through 2046 - Stock Titan
RVPH Q1 2026 Earnings: Narrower-Than-Expected Loss Drives 6.36% Stock AdvanceSpecial Dividend Alert - vinanet.vn
RVPH Q1 2026 Earnings: Narrower Loss Beats Estimates by 27.49%Product Revenue Analysis - vinanet.vn
Millennium entities (RVPH) disclose 1.07M-share, 8.2% Reviva Pharmaceuticals stake - Stock Titan
Reviva Pharmaceuticals (RVPH) Soars 17.47% to $0.47, Testing Key Resistance ZoneOvernight Profile - dars.gov.et
UBS Group (RVPH) exits Reviva Pharmaceuticals stake in updated report - Stock Titan
Reviva Pharmaceuticals (RVPH) Q1 2026 Earnings: Narrower Loss Surprises, Stock Dips on No Revenue Milestones - dars.gov.et
Reviva Pharmaceuticals Holdings Inc. (RVPH) Faces Steep Decline, Approaches Critical Support at $0.40Factor Crowding - dars.gov.et
RVPH Q1 2026 Earnings: Narrower Loss Surprises but Shares Slide on Pipeline UncertaintySaaS Earnings Trends - vinanet.vn
REVIVA PHARMA HLDGS INC by Reviva Pharmaceuticals Holdings, Inc. Market Sentiment - Benzinga España
Reviva Pharmaceuticals Holdings, Inc. Revenue Breakdown – OTC:RVPH - TradingView
Reviva Pharmaceuticals (RVPH) Surges 11.9%: Key Levels and What Comes NextRisk Reversal - dars.gov.et
RVPH SEC FilingsREVIVA PHARMACEUTICALS HOLDINGS, INC. 10-K, 10-Q, 8-K Forms - Stock Titan
Operating margin % of Reviva Pharmaceuticals Holdings, Inc. – OTC:RVPH - TradingView
Delisting of Securities from The Nasdaq Stock Market - manilatimes.net
Reviva Pharmaceuticals Holdings (NASDAQ: RVPH) — Files Form 25 to remove Common Stock from Nasdaq listing - Stock Titan
Reviva Pharmaceuticals Holdings (RVPH) Plunges 10% as Key Support NearsIV Expansion Alert - DonanımHaber
Reviva Pharmaceuticals (RVPH) Hovers Near Support Amid Minimal Price MovementDonchian Channel - dars.gov.et
Diluted earnings per share (diluted EPS) of Reviva Pharmaceuticals Holdings, Inc. – OTC:RVPH - TradingView
Enterprise value of Reviva Pharmaceuticals Holdings, Inc. – OTC:RVPH - TradingView
Price to earnings forward of Reviva Pharmaceuticals Holdings, Inc. – OTC:RVPH - TradingView
Enterprise value to EBIT forward of Reviva Pharmaceuticals Holdings, Inc. – OTC:RVPH - TradingView
Reviva Pharmaceuticals (RVPH) Q1 2026 Earnings: Narrower Loss Exceeds Expectations as Pipeline Progress ContinuesDividend Growth Analysis - dars.gov.et
Reviva Pharmaceuticals Holdings, Inc. Actuals & Estimates (OTC:RVPH) - TradingView
RVPH Forecast — Price Target — Prediction for 2027 - TradingView
Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing - The Manila Times
RVPH: Brilaroxazine shows strong efficacy, safety, and durability in schizophrenia, with NDA targeted for 2028 - TradingView
RVPH Q1 2026 Earnings: Narrower Loss Surprises but Stock DeclinesEarnings Cycle Outlook - Bölüm Sonu Canavarı
Reviva Pharmaceuticals to Present at the Life Sciences Investor Forum on June 24th - marketscreener.com
Reviva Pharmaceuticals (RVPH) Q1 2026 Earnings: EPS Surpasses Estimates as Pipeline Progress Offsets No RevenueStrong Earnings Momentum - po-news-eg.net
Reviva Pharmaceuticals Holdings Inc (RVPH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Reviva Pharmaceuticals Holdings Inc (RVPH) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Reviva Pharmaceuticals Holdings Inc (RVPHW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Reviva Pharmaceuticals Holdings Inc (RVPHW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Reviva Pharmaceuticals Holdings Inc - TradingKey
Reviva Pharmaceuticals Holdings Inc (RVPH) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Reviva Pharmaceuticals Holdings Inc (RVPHW) Institutional Confidence - TradingKey
Reviva Pharmaceuticals Holdings Inc (RVPHW) Valuation: PE, PB & Fair Value Analysis - TradingKey
Reviva Pharmaceuticals Holdings Inc (RVPHW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Reviva Pharmaceuticals Holdings Inc (RVPHW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Reviva Pharmaceuticals Holdings Inc (RVPHW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Reviva Pharmaceuticals Holdings Inc (RVPHW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Reviva Pharmaceuticals (RVPH) Sinks 10% as Stock Tests Key Support at $0.65Parabolic SAR - newsline.com
0.14%
0.15%
Capitalizzazione:
|
Volume (24 ore):